Skip to main content
. 2018 Dec 10;11:8803–8813. doi: 10.2147/OTT.S178446

Figure 1.

Figure 1

Relative TRIM37 expression in GC tissues and its clinical significances.

Notes: (A, B) qRT-PCR analysis of TRIM37 mRNA expression in GC tumor tissues and paracancerous control tissues. (C) Western blot analysis of TRIM37 protein expression in GC tumor tissues and paracancerous control tissues. (D) Representative IHC images of TRIM37 protein expression in clinical GC samples with or without metastasis and paracancerous control tissues. (E) Quantitative evaluation of TRIM37 protein expression in tumor tissues and paracancerous control tissues on the basis of staining scores. (F) Scatterplots of the average staining scores of TRIM37 expression in patients without or with metastasis. (G) Kaplan–Meier analysis of the correlation between TRIM37 expression and the overall survival of patients with GC. *P<0.05.

Abbreviations: GC, gastric cancer; IHC, immunohistochemistry; qRT-PCR, quantitative reverse transcription polymerase chain reaction; TRIM37, tripartite motif containing 37.